| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NATURE09764 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/nature09764 |
| P698 | PubMed publication ID | 21307933 |
| P50 | author | National Human Genome Research Institute | Q1634459 |
| Eric D. Green | Q5386338 | ||
| P2093 | author name string | Mark S Guyer | |
| P2860 | cites work | The Icelandic Healthcare Database and informed consent | Q47852963 |
| Genetics of type 2 diabetes. | Q51400285 | ||
| Multidimensional results reporting to participants in genomic studies: getting it right. | Q53071561 | ||
| Ethics. DNA returned to tribe, raising questions about consent | Q56780005 | ||
| The case for a US prospective cohort study of genes and environment | Q59051741 | ||
| Keeping Pace with the Times — The Genetic Information Nondiscrimination Act of 2008 | Q60016790 | ||
| Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta3-adrenergic receptor gene | Q73807082 | ||
| Emerging therapies for cystic fibrosis lung disease | Q84975734 | ||
| Initial sequencing and analysis of the human genome | Q21045365 | ||
| Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project | Q21061203 | ||
| Clinical trials and medical care: defining the therapeutic misconception | Q21144663 | ||
| A turning point in cancer research: sequencing the human genome | Q22065518 | ||
| The use of racial, ethnic, and ancestral categories in human genetics research | Q22066114 | ||
| Potential etiologic and functional implications of genome-wide association loci for human diseases and traits | Q22066284 | ||
| The knockout mouse project | Q22122054 | ||
| Initial impact of the sequencing of the human genome | Q22122172 | ||
| Finding the missing heritability of complex diseases | Q22122198 | ||
| Finishing the euchromatic sequence of the human genome | Q22122488 | ||
| A vision for the future of genomics research | Q22337251 | ||
| Research ethics and the challenge of whole-genome sequencing | Q24550756 | ||
| Complement factor H polymorphism in age-related macular degeneration | Q24553334 | ||
| EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib | Q24561953 | ||
| The NCBI dbGaP database of genotypes and phenotypes | Q24569609 | ||
| International network of cancer genome projects | Q24611474 | ||
| From structure to function: the ecology of host-associated microbial communities | Q24612050 | ||
| A map of human genome variation from population-scale sequencing | Q24617794 | ||
| A human gut microbial gene catalogue established by metagenomic sequencing | Q24618931 | ||
| The NIH Human Microbiome Project | Q24642619 | ||
| DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome | Q24644436 | ||
| IDH1 and IDH2 mutations in gliomas | Q24648948 | ||
| Genetic research and health disparities | Q24650579 | ||
| Signatures of mutation and selection in the cancer genome | Q39737975 | ||
| The SNP Consortium website: past, present and future | Q39790360 | ||
| MYH9 is associated with nondiabetic end-stage renal disease in African Americans | Q24653027 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis | Q24656576 | ||
| Prepublication data sharing | Q26283296 | ||
| The case for cloud computing in genome informatics | Q27499446 | ||
| Inhibition of Mutated, Activated BRAF in Metastatic Melanoma | Q27860458 | ||
| Sequencing technologies - the next generation | Q27860568 | ||
| Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma | Q27860881 | ||
| A gene-expression signature as a predictor of survival in breast cancer | Q27860945 | ||
| Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel | Q28196881 | ||
| Trastuzumab-based therapy for patients with HER2-positive breast cancer: from early scientific development to foundation of care | Q28254707 | ||
| Angiotensin II blockade and aortic-root dilation in Marfan's syndrome | Q28285199 | ||
| Genomewide association studies and assessment of the risk of disease | Q28288414 | ||
| A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer | Q28297827 | ||
| Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project | Q28301622 | ||
| Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies | Q28752220 | ||
| The A's, G's, C's, and T's of health disparities | Q28752470 | ||
| Integrating common and rare genetic variation in diverse human populations | Q29547220 | ||
| Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia | Q29547900 | ||
| A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells | Q29614565 | ||
| Identification of functional elements and regulatory circuits by Drosophila modENCODE | Q29617551 | ||
| Epigenetic modifications and human disease | Q29619753 | ||
| The NIH Roadmap Epigenomics Mapping Consortium | Q29619856 | ||
| Advances in understanding cancer genomes through second-generation sequencing | Q30014827 | ||
| Antibodypedia, a portal for sharing antibody and antigen validation data | Q31166222 | ||
| American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer | Q33303529 | ||
| Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome | Q33336718 | ||
| Structural variation in the human genome and its role in disease | Q33522758 | ||
| Information access. Prepublication data release, latency, and genome commons | Q33638174 | ||
| Glad you asked: participants' opinions of re-consent for dbGap data submission | Q33689894 | ||
| Robust replication of genotype-phenotype associations across multiple diseases in an electronic medical record | Q33773017 | ||
| PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations | Q33808357 | ||
| Debating clinical utility | Q33832923 | ||
| Anonymization of electronic medical records for validating genome-wide association studies | Q33842905 | ||
| Direct sequencing of the human microbiome readily reveals community differences | Q33965950 | ||
| Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. | Q34013022 | ||
| Annotating non-coding regions of the genome | Q34023095 | ||
| Do genetic and individual risk factors moderate the efficacy of motivational enhancement therapy? Drinking outcomes with an emerging adult sample | Q34034252 | ||
| New therapeutic approaches to mendelian disorders | Q34136273 | ||
| Ancestry and disease in the age of genomic medicine | Q34143193 | ||
| A decade's perspective on DNA sequencing technology | Q34163657 | ||
| Epigenomics reveals a functional genome anatomy and a new approach to common disease | Q34207844 | ||
| Future health applications of genomics: priorities for communication, behavioral, and social sciences research | Q34301870 | ||
| Serving the enterprise and beyond with informatics for integrating biology and the bedside (i2b2). | Q34399891 | ||
| Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose | Q34423204 | ||
| The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen | Q34653100 | ||
| Enhancing the feasibility of large cohort studies | Q34787904 | ||
| American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy | Q34935716 | ||
| Next generation disparities in human genomics: concerns and remedies | Q35008340 | ||
| Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. | Q35080445 | ||
| Integrating genetic information resources with an EHR. | Q35725119 | ||
| Analyses of deep mammalian sequence alignments and constraint predictions for 1% of the human genome | Q35840707 | ||
| Targeted cancer therapy | Q35953128 | ||
| Applications of nanobiotechnology in clinical diagnostics | Q36949512 | ||
| Managing incidental findings in human subjects research: analysis and recommendations | Q36954360 | ||
| A genecentric Human Protein Atlas for expression profiles based on antibodies | Q37231349 | ||
| The use of genomics in clinical trial design | Q37284262 | ||
| Instrumenting the health care enterprise for discovery research in the genomic era. | Q37363172 | ||
| Linking somatic genetic alterations in cancer to therapeutics | Q37425870 | ||
| The genetics of Crohn's disease | Q37488205 | ||
| Fragile X syndrome: from molecular genetics to therapy. | Q37590581 | ||
| Pharmacogenetics of antiretrovirals | Q37594986 | ||
| Using genetic diagnosis to determine individual therapeutic utility | Q37613688 | ||
| Recent advances and method development for drug target identification | Q37651785 | ||
| PhenX: a toolkit for interdisciplinary genetics research | Q37692105 | ||
| Newborn screening for treatable genetic conditions: past, present and future | Q37759830 | ||
| Autophagy and Crohn's disease: at the crossroads of infection, inflammation, immunity, and cancer | Q37764367 | ||
| Microfluidics in macro-biomolecules analysis: macro inside in a nano world | Q37765217 | ||
| An overview of newborn screening | Q37784965 | ||
| Health information technology: laying the infrastructure for national health reform | Q38429233 | ||
| P433 | issue | 7333 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | data ethics | Q45933174 |
| P304 | page(s) | 204-213 | |
| P577 | publication date | 2011-02-01 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Charting a course for genomic medicine from base pairs to bedside | |
| P478 | volume | 470 |
| Q36595655 | "Is it really worth it to get tested?": primary care patients' impressions of predictive SNP testing for colon cancer |
| Q35101415 | 'Information is information': a public perspective on incidental findings in clinical and research genome-based testing |
| Q35012563 | 'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project |
| Q34496202 | A 26-hour system of highly sensitive whole genome sequencing for emergency management of genetic diseases |
| Q40391326 | A Framework for Prioritizing Research Investments in Precision Medicine |
| Q38429749 | A Knowledge-based System for Intelligent Support in Pharmacogenomics Evidence Assessment: Ontology-driven Evidence Representation and Retrieval |
| Q54996932 | A Next-Generation Sequencing Primer-How Does It Work and What Can It Do? |
| Q38665110 | A Proposed Process for Reliably Updating the Common Rule |
| Q28652365 | A community assessment of privacy preserving techniques for human genomes |
| Q92205037 | A comparison of genomic laboratory reports and observations that may enhance their clinical utility for providers and patients |
| Q31000681 | A conceptual model for translating omic data into clinical action |
| Q34163657 | A decade's perspective on DNA sequencing technology |
| Q43432135 | A genetic counselor's guide to using next-generation sequencing in clinical practice |
| Q40710403 | A knowledge base for tracking the impact of genomics on population health |
| Q57780718 | A market in the making: the past, present and future of direct-to-consumer genomics |
| Q36238017 | A national agenda for the future of pathology in personalized medicine: report of the proceedings of a meeting at the Banbury Conference Center on genome-era pathology, precision diagnostics, and preemptive care: a stakeholder summit |
| Q36776351 | A population approach to precision medicine |
| Q35145003 | A quick guide to genomics and bioinformatics training for clinical and public audiences. |
| Q42416713 | A role for fibrocytes in peritoneal fibrosis? |
| Q37377663 | A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation. |
| Q37633177 | A survey of informatics approaches to whole-exome and whole-genome clinical reporting in the electronic health record |
| Q90754603 | A systems approach to clinical oncology uses deep phenotyping to deliver personalized care |
| Q34521706 | A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer |
| Q28268019 | A vision for ubiquitous sequencing |
| Q36529860 | A visual and curatorial approach to clinical variant prioritization and disease gene discovery in genome-wide diagnostics. |
| Q36874879 | Academic general internal medicine: a mission for the future |
| Q34639949 | Accounting for eXentricities: analysis of the X chromosome in GWAS reveals X-linked genes implicated in autoimmune diseases |
| Q21245493 | Advanced health biotechnologies in Thailand: redefining policy directions |
| Q28660588 | Advances in genome studies in plants and animals |
| Q36906559 | Advancing genomic research and reducing health disparities: what can nurse scholars do? |
| Q35027068 | An emerging place for lung cancer genomics in 2013. |
| Q28709495 | An i2b2-based, generalizable, open source, self-scaling chronic disease registry |
| Q33565033 | An inter-professional approach to personalized medicine education: one institution's experience |
| Q30581758 | An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. |
| Q30488957 | An open access pilot freely sharing cancer genomic data from participants in Texas |
| Q51792929 | An optical nanoruler based on a conjugated polymer-silver nanoprism pair for label-free protein detection. |
| Q28468449 | Analysis of Genetic Variation in CYP450 Genes for Clinical Implementation |
| Q36791878 | Antibody Therapeutics in Oncology |
| Q47284170 | Applications of pharmacogenomics in regulatory science: a product life cycle review |
| Q30842220 | Approaches to integrating germline and tumor genomic data in cancer research |
| Q35452558 | Aquaporin-2: new mutations responsible for autosomal-recessive nephrogenic diabetes insipidus-update and epidemiology. |
| Q26774155 | Assessing the Costs and Cost-Effectiveness of Genomic Sequencing |
| Q90461024 | Assessing the Implementation of Pharmacogenomic Panel-Testing in Primary Care in the Netherlands Utilizing a Theoretical Framework |
| Q43505071 | Assessing the integration of genomic medicine in genetic counseling training programs |
| Q48503018 | Assessing the readiness of precision medicine interoperabilty: An exploratory study of the National Institutes of Health genetic testing registry. |
| Q33629929 | Assessment of knowledge about biobanking among healthcare students and their willingness to donate biospecimens |
| Q36592287 | Associations between risk perceptions and worry about common diseases: a between- and within-subjects examination |
| Q36622292 | Asthma genetics and personalised medicine |
| Q28659644 | Attitudes of Canadian researchers toward the return to participants of incidental and targeted genomic findings obtained in a pediatric research setting |
| Q36027086 | Attitudes to incorporating genomic risk assessments into population screening programs: the importance of purpose, context and deliberation |
| Q27320580 | Attitudes towards the sharing of genetic information with at-risk relatives: results of a quantitative survey |
| Q36658240 | Automatic Placement of Genomic Research Results in Medical Records: Do Researchers Have a Duty? Should Participants Have a Choice? |
| Q49924790 | Awareness and attitude of the public toward personalized medicine in Korea. |
| Q52311025 | Behavioral Economics: A New Lens for Understanding Genomic Decision Making. |
| Q37060585 | Behavioral and psychosocial responses to genomic testing for colorectal cancer risk |
| Q38672716 | Beliefs about Genetically Targeted Care in African Americans |
| Q42696428 | Between hype and hope: What is really at stake with personalized medicine? |
| Q28390595 | Beyond base pairs to bedside: a population perspective on how genomics can improve health |
| Q91933337 | Beyond the hype of big data and artificial intelligence: building foundations for knowledge and wisdom |
| Q34198963 | BioQ: tracing experimental origins in public genomic databases using a novel data provenance model |
| Q33997918 | Biomarkers in women's cancers, gynecology, and obstetrics |
| Q42988567 | Biomedical data privacy: problems, perspectives, and recent advances |
| Q30386563 | Building International Genomics Collaboration for Global Health Security. |
| Q92506536 | Building evidence and measuring clinical outcomes for genomic medicine |
| Q38352326 | Building the Human Vaccines Project: strategic management recommendations and summary report of the 15-16 July 2014 business workshop |
| Q37438867 | Bumps along the translational pathway: anticipating uptake of tailored smoking cessation treatment |
| Q36078688 | CHALLENGES FOR IMPLEMENTING A PTSD PREVENTIVE GENOMIC SEQUENCING PROGRAM IN THE U.S. MILITARY. |
| Q40599031 | CSN and CAVA: variant annotation tools for rapid, robust next-generation sequencing analysis in the clinical setting |
| Q42288102 | Can learning health systems help organisations deliver personalised care? |
| Q28647138 | Canadian Open Genetics Repository (COGR): a unified clinical genomics database as a community resource for standardising and sharing genetic interpretations |
| Q37637598 | Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases. |
| Q35447163 | Cardiovascular pharmacogenomics |
| Q36487290 | Cardiovascular pharmacogenomics: the future of cardiovascular therapeutics? |
| Q30250279 | Causality at the dawn of the 'omics' era in medicine and in nephrology |
| Q37087227 | Challenges in IBD research: update on progress and prioritization of the CCFA's research agenda |
| Q26750544 | Challenges, Solutions, and Quality Metrics of Personal Genome Assembly in Advancing Precision Medicine |
| Q36997918 | Characterizing biobank organizations in the U.S.: results from a national survey |
| Q28655937 | Characterizing genetic variants for clinical action |
| Q37977297 | Charting ELSI's future course: lessons from the recent past |
| Q40843083 | Choice of transcripts and software has a large effect on variant annotation |
| Q39681528 | Chromatin: a key player in complex gene regulation and future cancer therapeutics. |
| Q35540606 | ClinSeK: a targeted variant characterization framework for clinical sequencing |
| Q38917557 | Clinical Decision Support: a 25 Year Retrospective and a 25 Year Vision |
| Q36380279 | Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era |
| Q28072159 | Clinical implementation of pharmacogenetics |
| Q33984635 | Clinical phenotype-based gene prioritization: an initial study using semantic similarity and the human phenotype ontology |
| Q41767458 | Clinical practice guidelines for translating pharmacogenomic knowledge to bedside. Focus on anticancer drugs |
| Q42068429 | Co-barcoded sequence reads from long DNA fragments: a cost-effective solution for "perfect genome" sequencing |
| Q37389775 | Communicating genetic risk information for common disorders in the era of genomic medicine |
| Q37171577 | Community leaders' perspectives on engaging African Americans in biobanks and other human genetics initiatives |
| Q30657467 | Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases |
| Q27009141 | Comprehensive genomic studies: emerging regulatory, strategic, and quality assurance challenges for biorepositories |
| Q42783811 | Computationally translating molecular discoveries into tools for medicine: translational bioinformatics articles now featured in JAMIA. |
| Q35814864 | Considerations in the construction of an instrument to assess attitudes regarding critical illness gene variation research |
| Q38635278 | Controlling the signal: Practical privacy protection of genomic data sharing through Beacon services |
| Q39630048 | Cost analysis of whole genome sequencing in German clinical practice |
| Q52717354 | Creating a buzz about insect genomes. |
| Q54211107 | Creating policy frameworks for public health genomics to benefit developing countries. |
| Q91241919 | Current conditions in medical genetics practice |
| Q34460060 | DNA sequencing and bar-coding using solid-state nanopores |
| Q42849591 | DawnRank: discovering personalized driver genes in cancer. |
| Q34371843 | De novo frameshift mutation in ASXL3 in a patient with global developmental delay, microcephaly, and craniofacial anomalies |
| Q84273227 | Decoding the genome beyond sequencing: the new phase of genomic research |
| Q48289244 | Defining genes using "blueprint" versus "instruction" metaphors: effects for genetic determinism, response efficacy, and perceived control |
| Q34216807 | Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems |
| Q33732477 | Design and implementation of a randomized controlled trial of genomic counseling for patients with chronic disease |
| Q28249073 | Developing genomic knowledge bases and databases to support clinical management: current perspectives |
| Q47427328 | Developing the "next generation" of genetic association databases for complex diseases |
| Q37156736 | Development of clinical decision support alerts for pharmacogenomic incidental findings from exome sequencing |
| Q36019509 | Diagnosis of mitochondrial disorders by concomitant next-generation sequencing of the exome and mitochondrial genome |
| Q37732473 | Dielectrophoresis for Biomedical Sciences Applications: A Review |
| Q35791516 | Disclosing pathogenic genetic variants to research participants: quantifying an emerging ethical responsibility |
| Q34513835 | Disclosure of genetic information and change in dietary intake: a randomized controlled trial |
| Q36637088 | Disclosure of incidental findings from next-generation sequencing in pediatric genomic research |
| Q37604560 | Discovery and functional assessment of gene variants in the vascular endothelial growth factor pathway |
| Q37590116 | Distinct communication patterns during genetic counseling for late-onset Alzheimer's risk assessment |
| Q56889703 | Distress, uncertainty, and positive experiences associated with receiving information on personal genomic risk of melanoma |
| Q37874857 | Do genetic variations alter the effects of exercise training on cardiovascular disease and can we identify the candidate variants now or in the future? |
| Q28654427 | Do researchers have an obligation to actively look for genetic incidental findings? |
| Q40691777 | EMR documentation of physician-patient communication following genomic counseling for actionable complex disease and pharmacogenomic results |
| Q46938355 | Educational challenges in implementing genomic medicine |
| Q34132349 | Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design |
| Q34866575 | Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders |
| Q41201094 | Effects of genetic and environmental risk assessment feedback on colorectal cancer screening adherence. |
| Q45841238 | Effects of providing personalized feedback of child's obesity risk on mothers' food choices using a virtual reality buffet |
| Q36610250 | Electronic barcoding of a viral gene at the single-molecule level |
| Q51580414 | Emerging personalized oncology: sequencing and systems strategies. |
| Q34583874 | Enabling genomic-phenomic association discovery without sacrificing anonymity |
| Q37746648 | Engaging Hmong adults in genomic and pharmacogenomic research: Toward reducing health disparities in genomic knowledge using a community-based participatory research approach |
| Q50082577 | Epigenetics and precision medicine in cardiovascular patients: from basic concepts to the clinical arena. |
| Q44525686 | Establish good genomic practice to guide medicine forward |
| Q38111610 | Establishing benchmarks and metrics for disruptive technologies, inappropriate and obsolete tests in the clinical laboratory |
| Q73121811 | Ethical Dimensions of Dynamic Consent in Data-Intense Biomedical Research—Paradigm Shift, or Red Herring? |
| Q28684652 | Ethical and legal implications of whole genome and whole exome sequencing in African populations. |
| Q28607430 | Ethical considerations of research policy for personal genome analysis: the approach of the Genome Science Project in Japan |
| Q37588389 | Ethical, legal, and social implications of incorporating genomic information into electronic health records |
| Q35985180 | Ethics and neuropsychiatric genetics: a review of major issues |
| Q37599537 | Ethics of genetic testing and research in sport: a position statement from the Australian Institute of Sport. |
| Q99243176 | EuroGEMS.org: guide and links to online genetic and genomic educational resources, valuable for all levels |
| Q85972656 | Evidence required to demonstrate clinical utility of pharmacogenetic testing: the debate continues |
| Q29615382 | Exome sequencing as a tool for Mendelian disease gene discovery |
| Q34471832 | Exome sequencing of only seven Qataris identifies potentially deleterious variants in the Qatari population |
| Q35958596 | Experiences and attitudes of residents regarding a community-based genome cohort study in Japan: a population-based, cross-sectional study |
| Q37148894 | Exploring concordance and discordance for return of incidental findings from clinical sequencing |
| Q57298167 | FDA guidance for next generation sequencing-based testing: balancing regulation and innovation in precision medicine |
| Q34707985 | FLAGS, frequently mutated genes in public exomes |
| Q36936308 | Finding a place for genomics in health disparities research. |
| Q38719733 | Five-Year Bibliometric Review of Genomic Nursing Science Research |
| Q35187045 | Flexible positions, managed hopes: the promissory bioeconomy of a whole genome sequencing cancer study |
| Q46722457 | Framework for development of physician competencies in genomic medicine: report of the Competencies Working Group of the Inter-Society Coordinating Committee for Physician Education in Genomics |
| Q58739346 | Frequency and phenotype consequence of APOC3 rare variants in patients with very low triglyceride levels |
| Q42916400 | From helix to hematology: introduction to a collection of reviews on the emerging role of next-generation sequencing in hematology |
| Q36145524 | Funding and Forums for ELSI Research: Who (or What) is Setting the Agenda? |
| Q39181228 | Future of whole genome sequencing. |
| Q48261742 | GT-WGS: an efficient and economic tool for large-scale WGS analyses based on the AWS cloud service |
| Q57170220 | Gene editing in the context of an increasingly complex genome |
| Q36371895 | Gene-Diet Interactions in Complex Disease: Current Findings and Relevance for Public Health |
| Q37385974 | Gene-alcohol interactions identify several novel blood pressure loci including a promising locus near SLC16A9. |
| Q39664930 | Genes and plays: bringing ELSI issues to life |
| Q35185362 | Genes, race, and culture in clinical care: racial profiling in the management of chronic illness |
| Q30719211 | Genetic Knowledge Among Participants in the Coriell Personalized Medicine Collaborative |
| Q89553180 | Genetic Tests by Next Generation Sequencing in Children with Developmental Delay and/or Intellectual disability |
| Q35545490 | Genetic and environmental risk assessment and colorectal cancer screening in an average-risk population: a randomized trial. |
| Q36053127 | Genetic architecture of colorectal cancer |
| Q52607255 | Genetic counselling in the era of genomic medicine. |
| Q26830861 | Genetic data and electronic health records: a discussion of ethical, logistical and technological considerations |
| Q90267249 | Genetic determinants of BMI from early childhood to adolescence: the Santiago Longitudinal Study |
| Q36245131 | Genetic determinants of metabolism in health and disease: from biochemical genetics to genome-wide associations. |
| Q37962479 | Genetic epidemiology with a capital E, ten years after |
| Q33698750 | Genetic epidemiology: the potential benefits and challenges of using genetic information to improve human health |
| Q26829694 | Genetic research on biospecimens poses minimal risk |
| Q34734512 | Genetic simulation tools for post-genome wide association studies of complex diseases |
| Q36061256 | Genetic testing behavior and reporting patterns in electronic medical records for physicians trained in a primary care specialty or subspecialty |
| Q35190833 | Genetic testing for early detection of individuals at risk of coronary heart disease and monitoring response to therapy: challenges and promises |
| Q47162461 | Genetic testing for exercise prescription and injury prevention: AIS-Athlome consortium-FIMS joint statement |
| Q34571172 | Genetics and primary care: where are we headed? |
| Q53910369 | Genetics in population health science: strategies and opportunities. |
| Q37897478 | Genetics of monogenic autoinflammatory diseases: past successes, future challenges |
| Q54471750 | Genome diagnostics: next-generation sequencing, new genome-wide association studies and clinical challenges. |
| Q35754934 | Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND) |
| Q57910661 | Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations |
| Q59794799 | Genomic Interventions in Medicine |
| Q58555437 | Genomic Medicine Enters the Clinic: New Roles and Challenges for Hospital Librarians |
| Q64107530 | Genomic Testing for Human Health and Disease Across the Life Cycle: Applications and Ethical, Legal, and Social Challenges |
| Q38292930 | Genomic architecture of pharmacological efficacy and adverse events |
| Q38060203 | Genomic biomarkers for patient selection and stratification: the cancer paradigm. |
| Q57473341 | Genomic coordinates and continental distribution of 120 blood group variants reported by the 1000 Genomes Project |
| Q30779143 | Genomic data-sharing: what will be our legacy? |
| Q35082638 | Genomic markers to tailor treatments: waiting or initiating? |
| Q37649261 | Genomic medicine, health information technology, and patient care |
| Q38114005 | Genomic medicine: a decade of successes, challenges, and opportunities |
| Q36222657 | Genomic research in Zambia: confronting the ethics, policy and regulatory frontiers in the 21st Century |
| Q34154112 | Genomics and personalized medicine: CHRNA5-CHRNA3-CHRNB4 and smoking cessation treatment |
| Q30573833 | Genomics education for the public: perspectives of genomic researchers and ELSI advisors |
| Q64266394 | Genomics for All: International Open Science Genomics Projects and Capacity Building in the Developing World |
| Q41076261 | Genomics innovation: transforming healthcare, business, and the global economy |
| Q89024083 | Genotypes, phenotypes and whole genome sequence: Approaches from the My Life Our Future haemophilia project |
| Q46307768 | Geography of Genetics and Genomics Research Funding in Africa |
| Q37553286 | Grappling with genomic incidental findings in the clinical realm |
| Q34157264 | Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practice |
| Q30773132 | Guiding Oncology Patients Through the Maze of Precision Medicine |
| Q83572870 | Health behavior change: can genomics improve behavioral adherence? |
| Q38668130 | Healthcare provider education to support integration of pharmacogenomics in practice: the eMERGE Network experience |
| Q83239296 | High points and hurdles in the translation of genomics |
| Q37573642 | High-throughput gene expression and mutation profiling: current methods and future perspectives. |
| Q33838486 | Horizon scanning for translational genomic research beyond bench to bedside |
| Q88070942 | Hospital nursing leadership-led interventions increased genomic awareness and educational intent in Magnet settings |
| Q34302008 | How the electronic health record will change the future of health care |
| Q37641863 | INsPeCT: INtegrative Platform for Cancer Transcriptomics. |
| Q36383476 | IRB perspectives on the return of individual results from genomic research |
| Q27010356 | Identifiability in biobanks: models, measures, and mitigation strategies |
| Q37508182 | Identifying and characterizing regulatory sequences in the human genome with chromatin accessibility assays |
| Q39062032 | Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium. |
| Q33654267 | Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled Trial |
| Q37328458 | Implementing genomic medicine in the clinic: the future is here |
| Q38822784 | Implementing genomics and pharmacogenomics in the clinic: The National Human Genome Research Institute's genomic medicine portfolio |
| Q38195012 | Implementing individualized medicine into the medical practice |
| Q57640439 | Incidental Findings in Low-Resource Settings |
| Q36817320 | Incidental variants are critical for genomics |
| Q36935684 | Incorporating direct-to-consumer genomic information into patient care: attitudes and experiences of primary care physicians |
| Q28646998 | Informed consent and ethical re-use of African genomic data |
| Q36918240 | Institutional review board perspectives on obligations to disclose genetic incidental findings to research participants. |
| Q38368574 | Integrated Genomic Medicine: A Paradigm for Rare Diseases and Beyond |
| Q36894394 | Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations. |
| Q37082232 | Integrating stakeholder perspectives into the translation of cell-free fetal DNA testing for aneuploidy |
| Q38673851 | Integration of structural dynamics and molecular evolution via protein interaction networks: a new era in genomic medicine |
| Q37574182 | Interaction-based discovery of functionally important genes in cancers |
| Q37141077 | Interpretations of education about gene-environment influences on health in rural Ethiopia: the context of a neglected tropical disease |
| Q38614473 | Interpreting functional effects of coding variants: challenges in proteome-scale prediction, annotation and assessment |
| Q34378815 | Introducing a New Competency Into Nursing Practice |
| Q36944836 | Introduction to the special section on genomics |
| Q26864177 | Is personalized medicine achievable in obstetrics? |
| Q35740694 | Is the genomic translational pipeline being disrupted? |
| Q26825227 | Kidney disease: new technologies translate mechanisms to cure |
| Q36377746 | Knowledge integration at the center of genomic medicine |
| Q84935711 | Laparoscopic low anterior resection with total mesorectal excision for rectal cancer |
| Q52665484 | Large-Scale Genomic Biobanks and Cardiovascular Disease. |
| Q48083405 | Leading the way to genomic medicine |
| Q37574709 | Leaves imitate trees: Minnesota Hmong concepts of heredity and applications to genomics research |
| Q35927836 | Leveraging Epidemiologic and Clinical Collections for Genomic Studies of Complex Traits |
| Q35917327 | Leveraging Interaction between Genetic Variants and Mammographic Findings for Personalized Breast Cancer Diagnosis |
| Q35907547 | Looking back at genomic medicine in 2011. |
| Q35899657 | Machine learning derived risk prediction of anorexia nervosa |
| Q36206284 | Mapping the Ethics of Translational Genomics: Situating Return of Results and Navigating the Research-Clinical Divide |
| Q57643754 | Maternal perspectives on the return of genetic results: context matters |
| Q91876812 | Medical Genetics Ethics Case Collection: Discussion Materials for Medical Students in the Genomic Era |
| Q30808861 | Medical genomics: Gather and use genetic data in health care |
| Q31058146 | Merging Electronic Health Record Data and Genomics for Cardiovascular Research: A Science Advisory From the American Heart Association |
| Q35551190 | Methods of genomic competency integration in practice |
| Q42562683 | Mirror, mirror on the wall: which microbiomes will help heal them all? |
| Q41673720 | Misleading presentation of haemoglobin electrophoresis data |
| Q51717530 | Missing heritability, next-generation genome-wide association studies and primary cancer prevention: an Atlantean illusion? |
| Q37401998 | Mitochondrial protein functions elucidated by multi-omic mass spectrometry profiling. |
| Q38673397 | Molecular diagnostics for hereditary hearing loss in children |
| Q34345162 | Molecular genetic testing and the future of clinical genomics |
| Q28728358 | Molecular genomic research designs |
| Q92124426 | Multi-omic Dissection of Oncogenically Active Epiproteomes Identifies Drivers of Proliferative and Invasive Breast Tumors |
| Q38723253 | Multiancestry Study of Gene-Lifestyle Interactions for Cardiovascular Traits in 610 475 Individuals From 124 Cohorts: Design and Rationale |
| Q96128436 | Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics |
| Q39512936 | Multimodal dynamic profiling of healthy and diseased states for future personalized health care. |
| Q30387827 | NMR in structural genomics to increase structural coverage of the protein universe: Delivered by Prof. Kurt Wüthrich on 7 July 2013 at the 38th FEBS Congress in St. Petersburg, Russia |
| Q28728194 | Nanoinformatics: developing new computing applications for nanomedicine |
| Q88454830 | Neutral Theory, Disease Mutations, and Personal Exomes |
| Q34029677 | Next generation analytic tools for large scale genetic epidemiology studies of complex diseases |
| Q36721518 | Next-Generation Sequencing in the Genetics of Human Atrial Fibrillation |
| Q36367741 | Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings |
| Q38242485 | Next-generation sequencing technologies: breaking the sound barrier of human genetics |
| Q38029472 | Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders |
| Q33588592 | Non-coding-regulatory regions of human brain genes delineated by bacterial artificial chromosome knock-in mice |
| Q49918080 | Novel STIL Compound Heterozygous Mutations Cause Severe Fetal Microcephaly and Centriolar Lengthening. |
| Q42058226 | Novel cancer drivers: mining the kinome |
| Q40484720 | Nursing and Biobanking |
| Q38539222 | Nutrigenetics of cholesterol metabolism: observational and dietary intervention studies in the postgenomic era. |
| Q88370832 | Nutritional Genomics and Direct-to-Consumer Genetic Testing: An Overview |
| Q37237684 | On averages and peaks: how do people integrate attitudes about multiple diseases to reach a decision about multiplex genetic testing? |
| Q41969090 | Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project. |
| Q38037294 | Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. |
| Q37216033 | Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project |
| Q92506513 | Opportunities, resources, and techniques for implementing genomics in clinical care |
| Q37100793 | Other side of the coin for personalised medicine and healthcare: content analysis of 'personalised' practices in the literature |
| Q33751939 | PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics |
| Q47345659 | PRECISION MEDICINE: FROM DIPLOTYPES TO DISPARITIES TOWARDS IMPROVED HEALTH AND THERAPIES. |
| Q64096215 | Pairing pedagogical and genomic advances to prepare advanced practice nurses for the era of precision health |
| Q34527740 | Pathways to precision medicine in smoking cessation treatments |
| Q95326692 | Patient experience of uncertainty in cancer genomics: a systematic review |
| Q38607709 | Patient-centric trials for therapeutic development in precision oncology. |
| Q34346566 | Patient-controlled encrypted genomic data: an approach to advance clinical genomics |
| Q36724985 | Patients' perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project |
| Q35195408 | Personal genomes, quantitative dynamic omics and personalized medicine |
| Q47423850 | Personal utility is inherent to direct-to-consumer genomic testing. |
| Q92555536 | Personalized Medicine and the Power of Electronic Health Records |
| Q36543050 | Personalized medicine and access to health care: potential for inequitable access? |
| Q35082635 | Personalized medicine: new genomics, old lessons |
| Q38571728 | Personalizing chemotherapy dosing using pharmacological methods |
| Q35648041 | Perspectives on what is needed to implement genomic medicine |
| Q34201078 | Phylomedicine: an evolutionary telescope to explore and diagnose the universe of disease mutations |
| Q41445210 | Physician Assistant Genomic Competencies |
| Q47726388 | Physician Experiences and Understanding of Genomic Sequencing in Oncology. |
| Q89172581 | Physician Knowledge of Human Genetic Variation, Beliefs About Race and Genetics, and Use of Race in Clinical Decision-making |
| Q36415005 | Physicians and knowledge translation of statistics: Mind the gap. |
| Q92966277 | Polygenic risk-stratified screening for cancer: Responsibilization in public health genomics |
| Q35920941 | Practical Approaches for Detecting Selection in Microbial Genomes |
| Q41343778 | Practical considerations for implementing genomic information resources. Experiences from eMERGE and CSER. |
| Q28608217 | Practical considerations in genomic decision support: The eMERGE experience |
| Q91753409 | Pragmatic Trials in Genomic Medicine: The Integrating Pharmacogenetics In Clinical Care (I-PICC) Study |
| Q35809920 | Pragmatic and Ethical Challenges of Incorporating the Genome into the Electronic Medical Record |
| Q30249224 | Precision medicine in cardiology |
| Q36166107 | Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers |
| Q33959897 | Prenatal whole genome sequencing: just because we can, should we? |
| Q47213433 | Prioritizing diversity in human genomics research. |
| Q46144163 | Privacy Challenges of Genomic Big Data. |
| Q35033000 | Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium |
| Q36051664 | Progress of cancer genomics |
| Q37736390 | Proteogenomic integration reveals therapeutic targets in breast cancer xenografts |
| Q47923648 | Public Comments on Proposed Regulatory Reforms That Would Impact Biospecimen Research: The Good, the Bad, and the Puzzling. |
| Q33828222 | Public perspectives on biospecimen procurement: what biorepositories should consider |
| Q93360116 | Qualitative study of system-level factors related to genomic implementation |
| Q57785071 | Quantifying the potential of functional evidence to reclassify variants of uncertain significance in the categorical and Bayesian interpretation frameworks |
| Q34820081 | Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units |
| Q28741456 | Realizing the promise of population biobanks: a new model for translation |
| Q35764483 | Recent advances in biomarker discovery in solid organ transplant by proteomics |
| Q38260258 | Recent genetic findings in schizophrenia and their therapeutic relevance |
| Q30540771 | Recommendations for ethical approaches to genotype-driven research recruitment |
| Q45330172 | Relevance of genomics to healthcare and nursing practice |
| Q51161500 | Report on the 8th Annual Cold Spring Harbor/Wellcome Trust meeting on Pharmacogenomics and Personalized Medicine. |
| Q54257597 | Research Highlights: Highlights from the latest articles in chronic obstructive pulmonary disease genetics. |
| Q34117892 | Research priorities. ELSI 2.0 for genomics and society |
| Q34058750 | Resources and costs for microbial sequence analysis evaluated using virtual machines and cloud computing |
| Q30575241 | Return of results in the genomic medicine projects of the eMERGE network |
| Q34040535 | Returning findings within longitudinal cohort studies: the 1958 birth cohort as an exemplar |
| Q58529411 | Reviews of Science for Science Librarians: Genome-Wide Association Studies (GWAS) |
| Q43186471 | Risk factors and early detection of breast cancer: facts, questions, and genome-based perspectives |
| Q53085241 | Risk for Patient Harm in Canadian Genetic Counseling Practice: It's Time to Consider Regulation. |
| Q92310980 | Role of genomics literacy in reducing the burden of common genetic diseases in Africa |
| Q28728617 | Routine use of microbial whole genome sequencing in diagnostic and public health microbiology |
| Q35916535 | Scenario drafting for early technology assessment of next generation sequencing in clinical oncology |
| Q34051248 | Secure management of biomedical data with cryptographic hardware |
| Q28652195 | SecureMA: protecting participant privacy in genetic association meta-analysis |
| Q38743800 | Should Genetic Testing be Offered for Children? The Perspectives of Adolescents and Emerging Adults in Families with Li-Fraumeni Syndrome. |
| Q50451743 | Signal amplification by a self-assembled biosensor system designed on the principle of dockerin-cohesin interactions in a cellulosome complex. |
| Q36470908 | Social determinants of family health history collection |
| Q26770324 | Somatic DNA mutation analysis in targeted therapy of solid tumours |
| Q37885276 | Somatic variation and cancer: therapies lost in the mix. |
| Q54839504 | Stakeholder Perspectives on Public Health Genomics Applications for Sickle Cell Disease: A Methodology for a Human Heredity and Health in Africa (H3Africa) Qualitative Research Study. |
| Q38963936 | Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine |
| Q34288996 | Stewardship practices of U.S. biobanks |
| Q36868801 | Storytellers as partners in developing a genetics education resource for health professionals |
| Q101051322 | Strategic vision for improving human health at The Forefront of Genomics |
| Q30888341 | Supporting interoperability of genetic data with LOINC. |
| Q28542977 | Surveying Recent Themes in Translational Bioinformatics: Big Data in EHRs, Omics for Drugs, and Personal Genomics |
| Q37585907 | Sustained effects of online genetics education: a randomized controlled trial on oncogenetics |
| Q36915402 | Systematic functional regulatory assessment of disease-associated variants. |
| Q34557668 | Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach. |
| Q34285373 | Teaching health law. |
| Q36943861 | Test-Retest Reliability of the Genetics and Genomics in Nursing Practice Survey Instrument |
| Q39391925 | The 'missing heritability' of common disorders: should health researchers care? |
| Q36495128 | The Effect of Ethnicity on Human Axillary Odorant Production |
| Q28674604 | The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future |
| Q36802917 | The Fluid Mechanics of Genome Mapping |
| Q29109919 | The Future of Children's Health in the Genomic Era |
| Q27014740 | The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities |
| Q28657810 | The Human Genome Project: big science transforms biology and medicine |
| Q37006081 | The Human Microbiome Project: lessons from human genomics |
| Q40816093 | The Importance of Biological Databases in Biological Discovery |
| Q89127498 | The Influence of Adolescence on Parents' Perspectives of Testing and Discussing Inherited Cancer Predisposition |
| Q45954445 | The International Serious Adverse Events Consortium's data sharing model. |
| Q30585056 | The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine |
| Q49581003 | The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants. |
| Q89064481 | The Socio-Exposome: Advancing Exposure Science and Environmental Justice in a Post-Genomic Era |
| Q39284073 | The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings |
| Q61445856 | The added value of WES reanalysis in the field of genetic diagnosis: lessons learned from 200 exomes in the Lebanese population |
| Q38125937 | The application of next-generation sequencing in the autozygosity mapping of human recessive diseases |
| Q57455595 | The clinical imperative for inclusivity: Race, ethnicity, and ancestry (REA) in genomics |
| Q28386235 | The coming age of data-driven medicine: translational bioinformatics' next frontier |
| Q35894605 | The decision-making process of genetically at-risk couples considering preimplantation genetic diagnosis: initial findings from a grounded theory study. |
| Q37171542 | The disclosure of incidental genomic findings: an "ethically important moment" in pediatric research and practice |
| Q30249029 | The effect of communicating the genetic risk of cardiometabolic disorders on motivation and actual engagement in preventative lifestyle modification and clinical outcome: a systematic review and meta-analysis of randomised controlled trials. |
| Q38006632 | The emerging spectrum of allelic variation in schizophrenia: current evidence and strategies for the identification and functional characterization of common and rare variants |
| Q35034175 | The fiduciary relationship model for managing clinical genomic "incidental" findings |
| Q41926369 | The identification of novel potential injury mechanisms and candidate biomarkers in renal allograft rejection by quantitative proteomics |
| Q37883983 | The importance of biological databases in biological discovery |
| Q36639417 | The major histocompatibility complex in Old World camelids and low polymorphism of its class II genes |
| Q30234695 | The systemic nature of CKD. |
| Q27015999 | The transcriptome of cerebral ischemia |
| Q34675532 | The unintended implications of blurring the line between research and clinical care in a genomic age. |
| Q84973115 | Timing of laparoscopic surgery in the neoadjuvant treatment of rectal cancer |
| Q89497496 | Toward Integration of mHealth in Primary Care in the Netherlands: A Qualitative Analysis of Stakeholder Perspectives |
| Q42394160 | Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain |
| Q31115576 | Toward the integration of Omics data in epidemiological studies: still a "long and winding road". |
| Q30391847 | Towards precision medicine |
| Q39040571 | Training future physicians in the era of genomic medicine: trends in undergraduate medical genetics education. |
| Q37574725 | Translation and adaptation of skin cancer genomic risk education materials for implementation in primary care |
| Q34378848 | Translational bioinformatics embraces big data |
| Q38103070 | Translational utility of next-generation sequencing |
| Q35681250 | Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the spanish society of clinical pharmacology |
| Q36464788 | Type 2 Diabetes Genetics: Beyond GWAS. |
| Q28540676 | Usability evaluation of pharmacogenomics clinical decision support aids and clinical knowledge resources in a computerized provider order entry system: a mixed methods approach |
| Q37876693 | Using electronic health records to drive discovery in disease genomics |
| Q44409195 | Using the Diffusion of Innovations theory to understand the uptake of genetics in nursing practice: identifying the characteristics of genetic nurse adopters. |
| Q103029400 | Welcome to the new genomics: an introduction to the NHS Genomic Medicine Service for oral healthcare professionals |
| Q33970852 | What does it mean to be genomically literate?: National Human Genome Research Institute Meeting Report |
| Q35012569 | What is next after the genes for autoimmunity? |
| Q36412637 | What is translational genomics? An expanded research agenda for improving individual and population health |
| Q57201840 | What's a Genome Worth? |
| Q35836434 | When Should Genome Researchers Disclose Misattributed Parentage? |
| Q34081019 | When does an illness begin: genetic discrimination and disease manifestation |
| Q50333715 | Which attributes of whole genome sequencing tests are most important to the general population? Results from a German preference study. |
| Q45229605 | Whole genome prediction of bladder cancer risk with the Bayesian LASSO. |
| Q35776062 | Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings |
| Q36720898 | Why personalized medicine will fail if we stay the course |
| Q35657847 | Young smokers' interpretations of the estimated lung cancer risk associated with a common genetic variant of low penetrance |
| Q38109304 | iPOP goes the world: integrated personalized Omics profiling and the road toward improved health care |
| Q36887018 | rAAV-compatible MiniPromoters for restricted expression in the brain and eye. |
Search more.